Search the Newsreel

Vital Farms, Inc. Quarterly Earnings Report

ATA Creativity Global (AACG) Earnings Forecast: Future EPS & Revenue Growth Estimates

ATA Creativity Global (AACG) currently lacks an earnings forecast score, with the industry average being 8.39. Analysts, based on one rating, project a target price of $12.00, suggesting a significant upside of 775.91%, and recommend a "Buy" for the stock. However, the company has …

Vital Farms Reports Second Quarter 2026 Financial Results

Second Quarter Net Revenue of $166.0 Million Announces Successful Execution of Previously Disclosed Supply Control and Targeted Cost Savings Initiatives Grew Retail Dollar Share of the Shell Egg Category by More Than 200 Basis Points Year-Over-Year, Even as Category Pricing Fell Sharply Amid Industry-Wide …

Egg oversupply drives Vital Farms to a $31.1M Q2 loss

Vital Farms (Nasdaq: VITL) reported a Q2 2026 net loss of $31.1 million, a significant drop from a net income of $16.6 million in Q2 2025, primarily due to industry-wide egg oversupply and lower retail prices. Despite a 10.1% decrease in net revenue to …

Navitas Semiconductor (NVTS) Guides Higher And Adds A SiC Partnership, Is The Stock Cheap?

Navitas Semiconductor Corporation $NVTS Shares Purchased by Bank of New York Mellon Corp

Bank of New York Mellon Corp increased its stake in Navitas Semiconductor Corporation (NVTS) by 21.8% in the first quarter, now holding 566,465 shares valued at $4.97 million. Institutional investors collectively own 46.14% of NVTS, while analysts maintain a "Hold" rating with a consensus …

Mouser Now Stocking TE Connectivity's AMPFOIL ULTRA Connectors for Battery Energy Storage Systems (BESS) and Automotive Powertrains

Mouser Electronics has expanded its inventory to include TE Connectivity's AMPFOIL ULTRA connectors, which are designed for high-density FFC and FPC applications. These connectors feature a dual foil plug design, compact pitch, secure positive locking mechanism, and meet stringent vibration and automotive standards, making …

Arrowstreet Capital Limited Partnership Sells 328,169 Shares of Revvity Inc. $RVTY

Gravita India confirms completion of August 6 investor meeting with no UPSI shared

Savita Oil Technologies Schedules 65th Annual General Meeting on August 31, 2026

Savita Oil Technologies fixes Aug 21 record date for FY26 dividend payout

Natural Grocers by Vitamin Cottage (NGVC) Earnings Date and Reports 2026

Shareholders Must Own Natural Grocers by Aug. 17 for Dividend

AVITA Medical, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:RCEL) 2026-08-06

Vital Farms (VITL) Earnings Date and Reports 2026 $VITL

Vitalhub (VHI) Earnings Date and Reports 2026 $VHI

Vitalhub Corp. (VHI) Releases Q2 2026 Earnings: Revenue Rises to $606.1 Million

(INVH) and the Role of Price-Sensitive Allocations

This article provides an AI-generated analysis of Invitation Homes Inc. (INVH), highlighting a neutral sentiment across all time horizons. It suggests a "wait-and-see" approach and outlines three distinct trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—with specific entry, target, and stop-loss levels. The analysis …

Vitesse Energy (VTS) Stock Faces Hedge Gain Questions After Profit Rebound

Vitesse Energy (VTS) reported a rebound to profitability in Q2, with net income of US$33 million, largely driven by unrealized hedge gains rather than operational performance. While the company's dividend yield and price-to-sales multiple appear attractive, market skepticism remains due to the quality of …

Comvita schedules virtual investor call for FY26 full-year results

Does Revvity’s Q2 Beat, Higher Guidance and China Exit Alter the Bull Case for RVTY?

Revvity, Inc. reported past second-quarter 2026 results with sales of US$729.69 million, net income of US$51.82 million and diluted EPS from continuing operations of US$0.48, while also reaffirming a regular US$0.07 per-share quarterly dividend and issuing full-year 2026 revenue guidance of US$2.83 billion to …

Revvity Inc. Lifts Guidance After Strong Earnings

Revvity Inc. reported strong Q2 earnings, exceeding revenue and EPS guidance, leading to raised full-year targets. The Diagnostics segment and high-content screening orders were key growth drivers, while software revenue experienced volatility. The company also demonstrated strong cash flow, deleveraging progress, and an accelerated …

DaVita (DVA) Earnings Put Its Valuation Back In Focus

Why Revvity (RVTY) Stock Is Up Today

Shares of Revvity (NYSE:RVTY) jumped 3.1% after the life sciences company reported strong second-quarter 2026 results that exceeded Wall Street expectations and raised its full-year guidance. The company announced adjusted EPS of $1.41 on revenue of $729.68 million, driven by 11% organic growth in …

DaVita Stock Down in Pre-Market Despite Q2 Earnings Beat, Margins Down

DaVita (DVA) reported adjusted earnings of $4.02 per share in Q2 2026, surpassing the Zacks Consensus Estimate, with revenues of $3.55 billion also exceeding expectations. Despite beating earnings and revenue forecasts and seeing an increase in U.S. dialysis treatments, the company's stock fell in …

Analysts Offer Insights on Energy Companies: Cameco (CCJ), Vitesse Energy, Inc. (VTS) and Pembina Pipeline (PBA)

This article highlights bullish analyst sentiments for three energy companies: Cameco (CCJ), Vitesse Energy, Inc. (VTS), and Pembina Pipeline (PBA). Analysts from Stifel Nicolaus, Alliance Global Partners, and TD Cowen maintained "Buy" ratings for these respective companies, indicating potential upside from current stock levels. …

DaVita Inc. stock underperforms Wednesday when compared to competitors

Shares of DaVita Inc. (DVA) plunged 17.24% on Wednesday, closing at $188.69. This underperformance occurred during a mixed trading session where the Dow Jones Industrial Average rose, but the S&P 500 Index fell. The stock experienced its third consecutive day of losses.

Stifel raises Revvity stock price target to $110 on earnings beat

Stifel increased its price target for Revvity Inc (NYSE:RVTY) shares to $110 from $100, maintaining a Hold rating after the company reported strong Q2 2026 earnings that exceeded expectations. The beat was partly due to tariff refunds and tax savings, but also organic growth …

Barclays Adjusts Price Target on DaVita to $224 From $218

Barclays has increased its price target for DaVita Inc. (DVA) to $224 from $218. This adjustment follows other analyst updates, with BofA raising its target to $170 and Deutsche Bank to $265, reflecting varied outlooks on the healthcare facilities and services provider. The article …

Cleaner Water, Reduced Emissions Feature in Ingevity Report

Ingevity Corporation has released its 2025 Sustainability Report, "A Decade of Performance, a Future of Possibility," highlighting how its advanced materials and technologies contribute to environmental goals such as reduced emissions, extended infrastructure life, cleaner water, and the use of renewable raw materials. The …

DVA Q2 Earnings Call Centers on Clinical-Led Volume Growth

DaVita Inc. DVA used its second-quarter 2026 earnings call to emphasize improving mortality, stronger treatment volumes and expanded middle molecule clearance. Management kept its outlook intact while acknowledging commercial-mix and reimbursement pressure. Reported earnings of $4.02 per share topped the Zacks Consensus Estimate of …

Barclays Adjusts Price Target on Revvity to $115 From $105, Maintains Equalweight Rating

Barclays has increased its price target for Revvity (RVTY) shares to $115 from $105, while maintaining an Equalweight rating on the stock. This adjustment reflects an updated outlook from the analyst firm. The article also briefly mentions other analysts like Bernstein, Evercore ISI, and …

Insiders Could Have Profited By Holding onto Vital Farms Shares Despite 11% Drop

Vital Farms (NASDAQ:VITL) has seen its stock drop by 11% recently. Insiders who sold US$18 million worth of shares over the past year at an average price of US$50.78 would have been better off holding, as the current share price is US$12.15. Despite this, …

Bronstein, Gewirtz & Grossman, LLC Encourages Vital Farms, Inc. (VITL) Stockholders to Inquire about Securities Investigation

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Vital Farms, Inc. (NASDAQ:VITL) regarding alleged corporate wrongdoing. The firm encourages investors who purchased Vital Farms securities before May 8, 2025, and still hold them, to contact them for more information and to assist …

Beyond the Clinical: How Social Workers Drive Kidney Transplant Success

NORTHAMPTON, MA / ACCESS Newswire / August 5, 2026 / While kidney transplant is the optimal treatment path for end stage kidney disease (ESKD), complex logistical, financial and educational barriers can often stand in the way for many patients interested in pursuing it.NORTHAMPTON, MA …

Revvity posts solid Q2 2026 earnings growth